
A drug discovered and designed by an artificial intelligence system has reached the second phase of human clinical trials for the first time. This drug was developed by Insilico Medicine and is used to treat chronic lung disease.
According to Futurism, the drug NS018_055, developed for the treatment of "idiopathic pulmonary fibrosis", has been approved to go into the second phase of clinical trials. This means scientists can now see if the drug actually works.
According to Insilico researchers, if these experiments are successful, an important step will be taken in the field of using artificial intelligence to produce drugs, and we can expect a new era of drug research and development with this technology.
"The first drug candidate to move into Phase II is a real highlight of our ...
.....................................
Read more on our website:
For the first time, a drug made with artificial intelligence
Comments
Post a Comment